The enzyme industry has been impacted by a few announcements recently.
BASF exits partnership with Novozymes and Cargill on bio-based acrylic acid. The project has been running since 2008. Novozymes and Cargill will continue the work to develop the process. Press release from Novozymes.
Amyris has announced plans to launch µPharm (microPharm) Discovery and Production Platform, which the renewable products company says will provide the pharmaceutical industry with an integrated discovery and production process for therapeutic compounds. Sounds very similar to GSK’s commitment to incorporating “cell factories” not its sustainable manufacturing plans. Details here.
New biocatalysis company research released this week: 8 New Biocatalysis Companies profile.